8247 — BioSino Bio-technology and Science Cashflow Statement
0.000.00%
Last trade - 00:00- HK$78.14m
- HK$176.40m
- CNY263.07m
Annual cashflow statement for BioSino Bio-technology and Science, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 2.15 | 6.41 | 18.5 | -17.6 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -10.1 | 22 | 5.26 | -0.102 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.01 | -7.41 | -2.97 | -8.48 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 11.4 | 48.9 | 44.5 | -6.56 | — |
| Capital Expenditures | -16 | -6.55 | -16.5 | -16.6 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.015 | 0.771 | 15.4 | -1.12 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -15.9 | -5.78 | -1.12 | -17.7 | — |
| Financing Cash Flow Items | -11.8 | -10.6 | 14.9 | 11.1 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.5 | -44 | -10.8 | 10.2 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.4 | -0.984 | 32.9 | -13.9 | — |